Phase 4 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and young people between 1 and 21 years old (muscle strength testing is only done for those older than 3 years)
- People whose kidneys are working at a reduced level, measured by a specific formula using height and a blood test result called creatinine
- People whose most recent blood test showed a haemoglobin level (a measure of red blood cells) of at least 9.0 g/dL
- People whose most recent blood test showed a haemoglobin level below a certain limit based on age and sex: below 11.5 g/dL for children under 5; below 12.0 g/dL for children aged 5–12; below 12.5 g/dL for children aged 12–15 and females over 15; below 13.5 g/dL for males over 15
- People whose blood tests show low iron stores — specifically, a transferrin saturation of 20% or less AND a ferritin level of 100 ng/mL or less — may be placed into a specific group within the trial (confirm with trial site)
Who may not be able to join:
- People whose transferrin saturation (an iron level measurement) is below 5%
- People whose ferritin level (another iron store measurement) is below 10 ng/mL
- People who have received iron treatment or red blood cell stimulating medication (such as erythropoietin) in the 3 months before joining the trial
- People who have had a blood transfusion in the 4 months before joining the trial
- Children who are currently on haemodialysis (a machine-based kidney treatment)
- People whose kidney function is declining rapidly, or for whom a kidney transplant or dialysis is expected to be needed within 3 months
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Oleh Akchurin, M.D., Weill Cornell College of Medicine
Phone: 646-962-8313
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in muscle strength; Change in the percentage of transferrin saturation in the participants' blood
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.